Document is current
Any future updates will be listed below
-
Authors
Dulce, Raul A. https://orcid.org/0000-0003-1354-0180
Hatzistergos, Konstantinos E. https://orcid.org/0000-0003-2755-644X
Kanashiro-Takeuchi, Rosemeire M. https://orcid.org/0000-0002-7305-9172
Takeuchi, Lauro M. https://orcid.org/0000-0002-4517-9548
Balkan, Wayne https://orcid.org/0000-0003-0405-0489
Hare, Joshua M. https://orcid.org/0000-0002-7751-5032
-
Funding
Funding for this research was provided by:
Hellenic Foundation for Research and Innovation (15085)
National Institutes of Health (R01 HL094849)
- License Information
-
More Information
Article History
Accepted: 23 December 2024
First Online: 30 January 2025
Declarations
:
: R.M.KT. and J.M.H. are listed as co-inventors on patents on GHRH analogues which were assigned to the University of Miami and Veterans Affairs Department. J.M.H. previously owned equity in Biscayne Pharmaceuticals, license of intellectual property used in this study. Biscayne Pharmaceuticals did not provide funding for this study. JMH reported having a patent for cardiac cell-based therapy. He holds equity in Vestion Inc. and maintains a professional relationship with Vestion Inc. as a consultant and member of the Board of Directors and Scientific Advisory Board. Dr. Joshua Hare is the Chief Scientific Officer, a compensated consultant and advisory board member for Longeveron, and holds equity in Longeveron. Dr. Hare is also the co-inventor of intellectual property licensed to Longeveron. The University of Miami also stands to gain royalties from the commercialization of the IP.K.E.H. holds equity in Vestion Inc. He is also the co-inventor of intellectual property licensed to Vestion Inc and Longeveron. K.E.H. is the Chief Executive Officer for KosBio P.C. and holds equity in KosBio. He is also the co-inventor of intellectual property related to GHRH/GHRHR signaling, described in this work. Longeveron LLC, Vestion Inc. and KosBio P.C. did not participate in funding this work. All other authors have declared that no conflict of interest exists.
